KaNDy Therapeutics

KaNDy Therapeutics

KaNDy Therapeutics

A clinical-stage company focused on optimizing the potential ofNT-814 as a non-hormonal breakthrough treatment for multiple symptoms of themenopause.
Founded
2017
Raised
$32.9M
Follow us
Alexa global traffic share
Twitter followers
29 Aug 2018
£25,000,000
Venture capital (Series C)

KaNDy Therapeutics Raises £25M in Series C Financing

FinSMEs
+2